This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
The Department of Psychiatry and Behavioral Sciences at the University of Minnesota strives to fulfill the tripartite mission of the Medical School: excellence in teaching, research, and clinical service.
Our mission is to:
Please fill all the marked fields